195 related articles for article (PubMed ID: 30333385)
1. Large Cell Neuroendocrine Carcinoma of the Mediastinum Successfully Treated with Systemic Chemotherapy after Palliative Radiotherapy.
Hidaka T; Okuzumi S; Matsuhashi A; Takahashi H; Hata K; Shimizu S; Iwasaki Y
Intern Med; 2019 Feb; 58(4):563-568. PubMed ID: 30333385
[TBL] [Abstract][Full Text] [Related]
2. Multicentre phase II study of cisplatin-etoposide chemotherapy for advanced large-cell neuroendocrine lung carcinoma: the GFPC 0302 study.
Le Treut J; Sault MC; Lena H; Souquet PJ; Vergnenegre A; Le Caer H; Berard H; Boffa S; Monnet I; Damotte D; Chouaid C
Ann Oncol; 2013 Jun; 24(6):1548-52. PubMed ID: 23406729
[TBL] [Abstract][Full Text] [Related]
3. Large cell neuroendocrine carcinoma of the endometrium: A case report and literature review.
Tu YA; Chen YL; Lin MC; Chen CA; Cheng WF
Taiwan J Obstet Gynecol; 2018 Feb; 57(1):144-149. PubMed ID: 29458887
[TBL] [Abstract][Full Text] [Related]
4. Clinical responses of large cell neuroendocrine carcinoma of the lung to cisplatin-based chemotherapy.
Yamazaki S; Sekine I; Matsuno Y; Takei H; Yamamoto N; Kunitoh H; Ohe Y; Tamura T; Kodama T; Asamura H; Tsuchiya R; Saijo N
Lung Cancer; 2005 Aug; 49(2):217-23. PubMed ID: 16022916
[TBL] [Abstract][Full Text] [Related]
5. [Treatment strategy for neuroendocrine carcinoma of the lung].
Kawase A; Nagai K
Gan To Kagaku Ryoho; 2009 Oct; 36(10):1619-22. PubMed ID: 19838019
[TBL] [Abstract][Full Text] [Related]
6. Combination chemotherapy with irinotecan and cisplatin for large-cell neuroendocrine carcinoma of the lung: a multicenter phase II study.
Niho S; Kenmotsu H; Sekine I; Ishii G; Ishikawa Y; Noguchi M; Oshita F; Watanabe S; Nakajima R; Tada H; Nagai K
J Thorac Oncol; 2013 Jul; 8(7):980-4. PubMed ID: 23774385
[TBL] [Abstract][Full Text] [Related]
7. Primary large cell neuroendocrine carcinoma of the prostate in a hormone naive patient: A case report from Taiwan.
Tzou KY; Cheng WH; Lee WH; Ho CH
J Cancer Res Ther; 2018 Sep; 14(Supplement):S785-S788. PubMed ID: 30249904
[TBL] [Abstract][Full Text] [Related]
8. [Effectiveness of Nivolumab in Large-Cell Neuroendocrine Carcinoma of the Lung - A Report of Two Cases].
Daido W; Yamasaki M; Saito N; Ishiyama S; Deguchi N; Taniwaki M; Daga H; Ohashi N
Gan To Kagaku Ryoho; 2017 Jan; 44(1):59-62. PubMed ID: 28174381
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment with temozolomide in an elderly woman with advanced pulmonary large-cell neuroendocrine carcinoma: A case report.
Wei J; Dong XF; Hu ZL; Tang S; Lu YF
Medicine (Baltimore); 2018 Dec; 97(51):e13318. PubMed ID: 30572435
[TBL] [Abstract][Full Text] [Related]
10. Platinum Doublet plus Atezolizumab as First-line Treatment in Metastatic Large Cell Neuroendocrine Carcinoma: A Single Institution Experience.
Vrontis K; Economidou SC; Fotopoulos G
Cancer Invest; 2022 Feb; 40(2):124-131. PubMed ID: 34601985
[TBL] [Abstract][Full Text] [Related]
11. Clinical response of large cell neuroendocrine carcinoma of the lung to perioperative adjuvant chemotherapy.
Saji H; Tsuboi M; Matsubayashi J; Miyajima K; Shimada Y; Imai K; Kato Y; Usuda J; Kajiwara N; Uchida O; Ohira T; Hirano T; Mukai K; Kato H; Ikeda N
Anticancer Drugs; 2010 Jan; 21(1):89-93. PubMed ID: 19770636
[TBL] [Abstract][Full Text] [Related]
12. Unknown primary large cell neuroendocrine carcinoma (LCNEC) in the mediastinum.
Maeda A; Nakata M; Yasuda K; Yukawa T; Saisho S; Okita R; Hirami Y; Shimizu K
Gen Thorac Cardiovasc Surg; 2013 Sep; 61(9):542-5. PubMed ID: 23011520
[TBL] [Abstract][Full Text] [Related]
13. The Role of Systemic Therapy in the Management of Stage I Large Cell Neuroendocrine Carcinoma of the Lung.
Kujtan L; Muthukumar V; Kennedy KF; Davis JR; Masood A; Subramanian J
J Thorac Oncol; 2018 May; 13(5):707-714. PubMed ID: 29391287
[TBL] [Abstract][Full Text] [Related]
14. [An elderly patient with large cell neuroendocrine carcinoma(LCNEC)for whom chemotherapy with irinotecan and split-dose cisplatin(CDDP)proved very effective].
Tanno S; Onodera H; Inoue S; Honda R; Nagashima K; Ohsaki Y
Gan To Kagaku Ryoho; 2013 Sep; 40(9):1205-8. PubMed ID: 24047780
[TBL] [Abstract][Full Text] [Related]
15. Complexity in the treatment of pulmonary large cell neuroendocrine carcinoma.
Kozuki T; Fujimoto N; Ueoka H; Kiura K; Fujiwara K; Shiomi K; Mizobuchi K; Tabata M; Hamazaki S; Tanimoto M
J Cancer Res Clin Oncol; 2005 Mar; 131(3):147-51. PubMed ID: 15538626
[TBL] [Abstract][Full Text] [Related]
16. Long-term survivor of pulmonary combined large cell neuroendocrine carcinoma treated with nivolumab.
Oda R; Okuda K; Yamashita Y; Sakane T; Tatematsu T; Yokota K; Endo K; Nakanishi R
Thorac Cancer; 2020 Jul; 11(7):2036-2039. PubMed ID: 32379390
[TBL] [Abstract][Full Text] [Related]
17. Treatment options for patients with large cell neuroendocrine carcinoma of the lung.
Iyoda A; Makino T; Koezuka S; Otsuka H; Hata Y
Gen Thorac Cardiovasc Surg; 2014 Jun; 62(6):351-6. PubMed ID: 24719260
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy for pulmonary large cell neuroendocrine carcinoma: similar to that for small cell lung cancer or non-small cell lung cancer?
Sun JM; Ahn MJ; Ahn JS; Um SW; Kim H; Kim HK; Choi YS; Han J; Kim J; Kwon OJ; Shim YM; Park K
Lung Cancer; 2012 Aug; 77(2):365-70. PubMed ID: 22579297
[TBL] [Abstract][Full Text] [Related]
19. Large-cell neuroendocrine carcinoma with epidermal growth factor receptor mutation: possible transformation of lung adenocarcinoma.
Yanagisawa S; Morikawa N; Kimura Y; Nagano Y; Murakami K; Tabata T
Respirology; 2012 Nov; 17(8):1275-7. PubMed ID: 22943430
[No Abstract] [Full Text] [Related]
20. A clinicopathological study of peripheral, small-sized high-grade neuroendocrine tumours of the lung: differences between small-cell lung carcinoma and large-cell neuroendocrine carcinoma.
Isaka M; Nakagawa K; Ohde Y; Okumura T; Watanabe R; Ito I; Nakajima T; Kondo H
Eur J Cardiothorac Surg; 2012 Apr; 41(4):841-6. PubMed ID: 22219429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
